Sigma Planning Corp Ligand Pharmaceuticals Inc Transaction History

Sigma Planning Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 01, 2019	SELL	$107.38 - $129.34 $198,975 - $239,667	-1,853 Closed	0 $0
Q1 2019 May 01, 2019	BUY	$105.93 - $142.47 $196,288 - $263,996	1,853 New	1,853 $233,000
Q4 2018 Jan 31, 2019	SELL	$128.36 - $272.13 $168,665 - $357,578	-1,314 Closed	0 $0
Q3 2018 Nov 07, 2018	BUY	$211.18 - $274.49 $277,490 - $360,679	1,314 New	1,314 $361,000

249

17.7M

61K

7.8K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.91B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

Stay updated on Sigma Planning Corp with notifications on news.